Omission in Funding/Support | JAMA Network Open | JAMA Network
[Skip to Navigation]
Sign In
Correction
October 29, 2020

Omission in Funding/Support

JAMA Netw Open. 2020;3(10):e2027727. doi:10.1001/jamanetworkopen.2020.27727

In the Original Investigation titled “Trends in the Use of Stereotactic Body Radiotherapy for Treatment of Prostate Cancer in the United States,”1 published February 5, 2020, there was an omission in the Funding/Support section in the Article Information. Dr Hu’s research was supported by The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust. This article has been corrected.1

References
1.
Mahase  SS, D’Angelo  D, Kang  J, Hu  JC, Barbieri  CE, Nagar  H.  Trends in the use of stereotactic body radiotherapy for treatment of prostate cancer in the United States.   JAMA Netw Open. 2020;3(2):e1920471. doi:10.1001/jamanetworkopen.2019.20471PubMedGoogle Scholar
×